UppP is a key player in the lipid II cycle, recycling UPP to UP after glycan chain polymerization . This activity is critical for maintaining peptidoglycan synthesis rates. In Bacillus subtilis, UppP forms a synthetic lethal pair with BcrC, another UPP phosphatase, ensuring UP availability even under stress . Deletion of uppP in D. vulgaris confers resistance to 5-fluorouracil (5-FU), enabling its use as a counterselectable marker in genetic engineering .
Genetic Engineering Tool: A ΔuppP strain (JW710) of D. vulgaris was developed for markerless gene deletions. Reintroducing uppP restores 5-FU sensitivity, validating its role in nucleotide salvage pathways .
Bacitracin Resistance: UppP competes with bacitracin for UPP binding. Overexpression enhances bacitracin susceptibility, linking UppP activity to antibiotic resistance mechanisms .
Pseudohyphae Growth: In yeast systems, constitutive UppP expression indirectly affects pseudohyphae formation by altering metabolic maintenance, impacting recombinant protein yields .
Recombinant UppP is utilized in:
Antibiotic Research: Studying bacitracin resistance and cell wall biosynthesis pathways .
Genetic Systems: Enabling markerless deletions in sulfate-reducing bacteria like D. vulgaris .
Enzyme Engineering: Optimizing lipid carrier recycling for synthetic biology applications .
KEGG: dvl:Dvul_1427
Undecaprenyl-diphosphatase (uppP) plays a critical role in bacterial cell wall synthesis by catalyzing the dephosphorylation of undecaprenyl pyrophosphate (UPP) to undecaprenyl phosphate (UP). This conversion is essential because UP serves as a carrier lipid in the bacterial cell wall biosynthetic pathway. The process begins with farnesyl diphosphate synthase (FPPS) generating farnesyl pyrophosphate (FPP), which then condenses with 8 additional IPP molecules to form C55 undecaprenyl diphosphate (UPP) through a reaction catalyzed by undecaprenyl diphosphate synthase (UPPS). Subsequently, uppP converts UPP to UP, which is then utilized in the peptidoglycan biosynthesis pathway .
Due to its essential function and absence in human cells, uppP represents an attractive target for antibacterial drug development. The enzyme is also known as Bacitracin resistance protein in some literature, indicating its role in antibiotic resistance mechanisms .
For recombinant expression of Desulfovibrio vulgaris subsp. vulgaris uppP, Escherichia coli is the most commonly utilized expression system. The protein can be expressed with an N-terminal His-tag to facilitate purification. The His-tagged recombinant protein generally maintains its native enzymatic activity while providing the advantage of simplified purification through affinity chromatography .
Alternative methods for membrane protein expression have been developed, including fusion with bacteriorhodopsin tags at the N-terminus of target proteins, which can enhance expression levels and stability. This approach has opened new opportunities for investigating specific amino acids critical to enzymatic catalysis through site-directed mutagenesis .
The enzymatic activity of uppP can be assayed by measuring the dephosphorylation of undecaprenyl pyrophosphate. A typical assay includes:
Substrate preparation: Undecaprenyl pyrophosphate can be either purchased commercially or synthesized enzymatically using purified UPPS.
Reaction conditions: The standard reaction mixture contains:
Purified uppP enzyme (typically 0.1-1.0 μg)
Undecaprenyl pyrophosphate substrate (25-100 μM)
Buffer: Tris/PBS-based buffer (pH 8.0)
Essential divalent cations: MgCl₂ or CaCl₂ (5-10 mM) as uppP has an absolute requirement for magnesium or calcium ions
Detergent: A mild detergent such as Triton X-100 (0.1%) to maintain the membrane protein in solution
Activity measurement: The reaction can be monitored by:
Based on manufacturer recommendations for Desulfovibrio vulgaris subsp. vulgaris uppP:
Storage conditions:
Store lyophilized protein at -20°C or -80°C upon receipt
Aliquoting is necessary for multiple uses to avoid repeated freeze-thaw cycles
Working aliquots can be stored at 4°C for up to one week
Reconstitution protocol:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (recommended: 50%) for long-term storage
Aliquot the reconstituted protein for storage at -20°C/-80°C
| Storage Condition | Temperature | Maximum Duration |
|---|---|---|
| Lyophilized powder | -20°C/-80°C | Long-term |
| Reconstituted with glycerol | -20°C/-80°C | Long-term |
| Working solution | 4°C | Up to one week |
Site-directed mutagenesis is a powerful approach for identifying catalytically important residues in enzymes like uppP. Based on published research on uppP:
Target selection: Focus on the two consensus regions containing (E/Q)XXXE and PGXSRSXXT motifs, as well as the conserved histidine residue. Specific residues to target include:
E17 and E21 (in the glutamate-rich motif)
H30 (conserved histidine)
S173, R174, and T178 (in the PGXSRSXXT motif)
Mutagenesis protocol:
Design primers containing the desired mutations
Perform PCR-based mutagenesis using a high-fidelity DNA polymerase
Confirm mutations by DNA sequencing
Express and purify the mutant proteins using the same conditions as the wild-type
Functional analysis: Compare the enzymatic activities of wild-type and mutant proteins. Previous studies have shown that mutations E17A/E21A, H30A, S173A, R174A, and T178A resulted in complete loss of activity, confirming their essential roles in catalysis .
Structural implications: Combine mutagenesis results with computational modeling to propose a three-dimensional structure of the catalytic site and understand enzyme-substrate interactions in membrane bilayers.
Since uppP is an integral membrane protein, specialized computational approaches are required for structure prediction:
Rosetta membrane ab initio method: This approach can be used to generate a three-dimensional model of uppP using:
Predicted transmembrane topology
Fragment-based assembly
Energy minimization specific for membrane proteins
Incorporation of experimental constraints from mutagenesis studies
Molecular dynamics simulations: After generating an initial structure, molecular dynamics simulations in explicit lipid bilayers can:
Homology modeling: If structural homologs are identified, homology modeling can be employed using:
Template identification through sequence similarity searches
Alignment of target and template sequences
Model building and refinement
Validation using energy-based scoring functions
A systematic experimental design for studying uppP inhibitors should include:
Initial screening approach:
Develop a high-throughput enzymatic assay using purified recombinant uppP
Screen compound libraries to identify hits that inhibit enzymatic activity
Confirm hits using concentration-dependent inhibition studies
Determine IC₅₀ values for promising compounds
Design of control experiments:
Include positive controls (known phosphatase inhibitors)
Include negative controls (compounds with no expected activity)
Test against human phosphatases to assess selectivity
Include appropriate vehicle controls
Assessment of bactericidal activity:
Determine minimum inhibitory concentrations (MICs) against various bacterial species
Test for activity against antibiotic-resistant strains
Evaluate combinatorial effects with existing antibiotics
Assess potential for resistance development through serial passage experiments
Mechanism of action studies:
Perform enzyme kinetics to determine inhibition mechanism (competitive, non-competitive, etc.)
Use site-directed mutagenesis to identify binding sites
Employ computational docking to predict binding modes
Validate binding interactions through biophysical methods like isothermal titration calorimetry
Experimental design table:
| Phase | Experiment | Purpose | Controls | Analysis Method |
|---|---|---|---|---|
| 1 | In vitro enzyme assay | Initial screening | Known inhibitors | IC₅₀ determination |
| 2 | Bacterial growth inhibition | Antimicrobial activity | Standard antibiotics | MIC determination |
| 3 | Mechanism studies | Determine mode of action | Kinetic controls | Lineweaver-Burk plots |
| 4 | Resistance development | Assess barrier to resistance | Passage with sublethal doses | Resistance frequency |
| 5 | In vivo efficacy | Therapeutic potential | Standard antibiotic treatment | Survival analysis |
Top-down mass spectrometry is a powerful technique for analyzing intact proteins like recombinant uppP. The approach involves:
Sample preparation:
Purify recombinant uppP to high homogeneity (>90% as determined by SDS-PAGE)
Exchange into a mass spectrometry-compatible buffer
For membrane proteins like uppP, specialized detergents or nanodiscs may be required to maintain protein solubility
Mass spectrometry analysis:
Direct analysis of the intact protein
Fragmentation of the intact protein using techniques like electron transfer dissociation (ETD) or higher-energy collisional dissociation (HCD)
Collection of high-resolution MS and MS/MS spectra
Data processing workflow:
Deconvolution to determine the monoisotopic mass of the intact protein
Deisotoping to simplify complex isotope patterns
Searching fragmentation patterns against theoretical digests using specialized software like ProSight Lite
Applications:
Understanding the membrane topology of uppP is crucial for elucidating its function. Several complementary approaches can be employed:
These approaches have revealed that the two consensus regions containing (E/Q)XXXE and PGXSRSXXT motifs are localized near the aqueous interface of uppP and oriented toward the periplasmic site, suggesting that the enzyme's catalytic function occurs on the outer side of the plasma membrane .
Markerless genetic exchange systems offer advantages for studying gene function in bacteria without introducing antibiotic resistance markers. For studying uppP in Desulfovibrio vulgaris:
System design:
Construct a suicide vector containing:
Homologous regions flanking the uppP gene
A counter-selectable marker (e.g., sacB gene conferring sucrose sensitivity)
A positive selection marker (e.g., antibiotic resistance gene)
First crossover event:
Transform D. vulgaris with the suicide vector
Select transformants using the positive selection marker
Verify integration by PCR
Second crossover event:
Culture the first crossover mutants in media without selection
Plate on media containing the counter-selection agent (e.g., sucrose)
Screen colonies for loss of the positive selection marker
Verification and analysis:
Confirm gene deletion or modification by PCR and sequencing
Analyze phenotypic changes:
Cell wall integrity (osmotic sensitivity)
Antibiotic susceptibility (especially to cell wall-targeting antibiotics)
Growth characteristics
Morphological changes
Complementation studies:
As an integral membrane protein, uppP presents several challenges for recombinant expression. The following strategies can be employed to overcome these challenges:
Expression optimization:
Test multiple expression systems (E. coli strains, yeast, insect cells)
Optimize codon usage for the host organism
Use specialized expression vectors with tunable promoters
Test different fusion tags (His, GST, MBP, SUMO) for enhanced solubility
Utilize bacteriorhodopsin as a fusion tag, which has shown success for membrane proteins
Solubilization and stabilization:
Screen different detergents for optimal extraction and stability
Consider amphipols or nanodiscs for maintaining native-like lipid environments
Include stabilizing additives such as glycerol or specific lipids in buffers
Test the addition of specific lipids that might be required for activity
Functional validation: